Singapore markets open in 2 hours 43 minutes

Spectrum Pharmaceuticals, Inc. (SPPI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9749+0.0249 (+2.62%)
At close: 04:00PM EST
0.9800 +0.01 (+0.52%)
After hours: 05:13PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 232.82M
Enterprise value 100.67M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)2.93
Enterprise value/revenue N/A
Enterprise value/EBITDA -0.58

Trading information

Stock price history

Beta (5Y monthly) 1.84
52-week change 3-75.77%
S&P500 52-week change 314.07%
52-week high 34.5400
52-week low 30.8521
50-day moving average 31.4860
200-day moving average 32.5436

Share statistics

Avg vol (3-month) 35M
Avg vol (10-day) 33.64M
Shares outstanding 5163.96M
Implied shares outstanding 6N/A
Float 8141.96M
% held by insiders 11.52%
% held by institutions 158.07%
Shares short (30 Dec 2021) 412.77M
Short ratio (30 Dec 2021) 41.92
Short % of float (30 Dec 2021) 49.55%
Short % of shares outstanding (30 Dec 2021) 47.79%
Shares short (prior month 29 Nov 2021) 417.18M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 327 Dec 2012
Ex-dividend date 417 Dec 2012
Last split factor 21:25
Last split date 305 Sep 2002

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021


Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-47.16%
Return on equity (ttm)-136.06%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -145.49M
Net income avi to common (ttm)-168.59M
Diluted EPS (ttm)-1.0550
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)133.59M
Total cash per share (mrq)0.84
Total debt (mrq)3.04M
Total debt/equity (mrq)3.83
Current ratio (mrq)2.44
Book value per share (mrq)0.50

Cash flow statement

Operating cash flow (ttm)-122.44M
Levered free cash flow (ttm)-67.45M